Conclusion In the overall population, ADAS‐Cog13 did not achieve significance, but the hippocampus showed significant 18% slowing of atrophy.
← all excerpts
Efficacy and Safety of Oral Valiltramiprosate in APOE4/4 Homozygotes with Early AD: Topline Results from the APOLLOE4 Phase 3 Trial
1
—
—